Hypernative Raises $40M Series B to Remove Security Barriers to Web3 Mass Adoption
10.6.2025 14:30:00 CEST | Business Wire | Press Release
Hypernative, the leading provider of real-time threat prevention in Web3, today announced a $40 million Series B funding round co-led by Ten Eleven Ventures and Ballistic Ventures, with participation from StepStone Group, and existing investors boldstart ventures and IBI Tech Fund.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610162307/en/
Hypernative team
The funds will support the expansion of the company’s offering to include fraud prevention and wallet-level transaction protection—key steps toward building an end-to-end security platform for Web3. They will also fuel improvements to AI models through wider investment into high-quality training data, and support team growth to provide expert-driven risk analysis and customer support.
In 2024, Hypernative detected over $2.2 billion of losses from hacks, exploits, phishing, and fraud—a 22% jump from the previous year. Following the $1.4 billion Bybit hack in February, the industry is on track for another record-breaking year of security failures.
Hypernative uses AI-powered detection to respond to threats in real time, helping secure transactions and build trust across the Web3 ecosystem. The platform, used by over 200 customers to help protect more than $100 billion in assets, continues to evolve through ongoing integrations. With recent expansion into wallets, exchanges, and payment providers, Hypernative is contributing to a more unified approach to Web3 security.
Gal Sagie, Co-founder and CEO of Hypernative, said: “Web3 is at an inflection point: clear regulation is finally emerging, and institutional adoption is accelerating led by stablecoins and tokenized assets. But security remains the biggest blocker to mass adoption—and Hypernative is on a mission to close that gap.”
The funding round follows a number of exciting milestones for the company:
- Over the past year, Hypernative has more than doubled its network coverage to 60+ chains, including Solana and THORChain, enhancing security with hundreds of detectors to identify the industry's largest set of risks across not just security, but also financial, compliance and governance.
- The launch of Guardian, a real-time transaction security solution that protects against blind signing by simulating the outcome of every transaction before it is approved.
- Additionally, the team launched new ways of integrating Hypernative threat intelligence directly into a project's contracts or prior to block inclusion with sequencer integrations, frontend apps, liquidity pools, staking, and more.
“As leading cybersecurity investors, Ten Eleven recognizes how critical a robust security layer is to furthering adoption of Web3 technologies. Hypernative’s cohesive approach to real-time threat detection and response positions it as a foundational player in the future of decentralized ecosystems. That’s why we are proud to lead the Series B round and look forward to supporting the company through its next stage of growth,” said Mark Hatfield, Co-founder and General Partner of Ten Eleven Ventures.
"Hypernative is tackling the single greatest barrier to Web3’s mainstream future: trust. As attacks grow more sophisticated, the need for proactive, real-time security has never been more urgent," said Barmak Meftah, Co-founder and General Partner, Ballistic Ventures. "What Gal and the Hypernative team have built is not just innovative, it’s foundational to the next era of the internet. We're proud to back them as they scale their platform, expand their AI capabilities, and secure the path to mass adoption."
Hypernative's customer base ranges from chains, wallets, and protocols to exchanges, asset managers, and stablecoin issuers. More than 200 Web3 projects already rely on Hypernative for their security, with Aptos, Ethereum, Morpho, Movement, Sonic, Star Atlas, Wintermute, and ZKsync joining the list earlier this year.
To learn more about how Hypernative stops Web3 threats before they do any damage, visit: https://hypernative.io
About Hypernative
Hypernative is a real-time monitoring, risk detection and automated response solution that identifies threats with high accuracy and gives customers precious minutes to respond before exploits can do damage. The platform tracks both onchain and offchain data sources and uses battle-tested, sophisticated machine learning models, heuristics, simulations, and graph-based detections to identify over 300 risk types, from smart contract hacks and bridge security incidents to frontend compromises, market manipulations and private key theft. For more information, visit hypernative.io.
About Ten Eleven Ventures
Ten Eleven Ventures is the original cybersecurity-focused, global and stage-agnostic investment firm. The firm finds, invests in and helps grow top cybersecurity companies addressing critical digital security needs, tapping its team, network and experience to help build successful businesses. Since its founding, Ten Eleven Ventures has raised over $US1 billion and made over 60 cybersecurity investments across stages worldwide, including KnowBe4, Darktrace, Axis Security, Twistlock, Verodin, Cylance and Ping Identity. For more information, please visit 1011vc.com.
About Ballistic Ventures
Ballistic Ventures is a venture capital firm solely dedicated to early-stage cybersecurity and cyber-related companies. The partners have spent their entire careers defending against every cyber threat conceivable. Members of the firm have founded, operated, and funded over 100 successful cybersecurity firms – including Abnormal Security, AlienVault, ArcSight, Fortify, Mandiant, and Shape Security – led over 10,000 security professionals globally, and have 40+ years of experience in venture capital. Our experience provides entrepreneurs impactful support from people focused on the same mission. Our networks and relationships open doors for our founders. Learn more at ballisticventures.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610162307/en/
Contacts
Hypernative Press Contact:
Oliver Senchal
oliver@hypernative.io
Ten Eleven Ventures Press Contact:
Monsy Carlo
monsy@1011vc.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release
Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke
Digital Reef Turns to Vertical Farming to Reduce Data Centre Footprint in Partnership With Elevate Farms and Xange.com to Provide Digital Measurement, Reporting and Verification of Project's Environmental Impact Within the Reef Origin Ecosystem23.10.2026 13:12:00 CEST | Press Release
Elevate Farms Inc. and Digital Reef Ltd partnership supports mitigating environmental impact of global data centre expansion establishing a framework for Digital Reef’s infrastructure pipeline to support and utilize environmental assets generated by Elevate Farms' high-yield, closed-loop vertical farming operations. Traditional agriculture supply chains are replaced with optimized indoor facilities significantly reducing food production carbon emissions, water waste and local land constraints. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022393352/en/ Elevate Farms technology offers part of the solution to climate impact isolating food production from traditional agricultural farming variables saving over 95% of standard water requirements and significantly reducing farmland required for equivalent yields and logistical carbon. Digital Reef CEO Piers Slater stated "Digital Reef embrace data centre growth and environment
SLB Announces Third-Quarter 2026 Results23.10.2026 12:50:00 CEST | Press Release
SLB (NYSE: SLB) today announced results for the third-quarter 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261021694458/en/ The exterior of the SLB headquarters in Houston, Texas. Third-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeSept. 30, 2026Jun. 30, 2026Sept. 30, 2025SequentialYear-on-yearRevenue $9,449 $8,972 $8,928 5% 6% Income before taxes - GAAP basis $1,019 $1,018 $1,000 0% 2% Income before taxes margin - GAAP basis 10.8% 11.4% 11.2% -57 bps -42 bps Net income attributable to SLB - GAAP basis $735 $786 $739 -6% -1% Diluted EPS - GAAP basis $0.49 $0.52 $0.50 -6% -2% Adjusted EBITDA* $2,067 $1,899 $2,061 9% - Adjusted EBITDA margin* 21.9% 21.2% 23.1% 71 bps -121 bps Pretax segment operating income* $1,576 $1,404 $1,626 12% -3% Pretax segment operating margin* 16.7% 15.6% 18.2% 104 bps -153 bps Net income attributable to SLB, excluding charges & credits* $962 $833 $1,027
EZVIZ’s Smart Entry Solutions Have Consecutively Clinched the European Product Design Award and the Golden Pin Design Award, Indicating a Shift From Home Security to Living Enjoyment23.10.2026 11:58:00 CEST | Press Release
EZVIZ’s smart lock and AI-powered doorbell remained in the spotlight after IFA for bagging two world-class awards. The EP8 Ultra AI-powered video doorbell won the European Product Design Award 2026 (EPDA 2026), keeping leading in user-centric AI. Meanwhile, the DL50FVX smart lock was named the 2026 Golden Pin Design Award (GPDA) laureate for its intuitive access management and entered the finalist of the Best Design Awards. The growing prestige of EZVIZ’s smart home access management lineup marks a new chapter of providing living experiences with multi-level interaction, modern aesthetics, and emotional care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022441786/en/ Two representative models from EZVIZ's smart entry family take home prestigious awards for user-centric innovation. Founded in 2016, the EPDA aims to recognize well-thought-out products that break with tradition and improve everyday life. Continually refres
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release
Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom